GLENMARK PHARMACEUTICALS LTD. - Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg
30 Oct 2015
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated , titled "Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg".
Source:
BSE India